艾滋病患者自杀的风险. 一个国家评估
T R Coté1, R J Biggar, A L Dannenberg
1National Cancer Institute, Viral Epidemiology Section, Rockville, Md 20852.
JAMA
|October 21, 1992
概括
获得性免疫缺陷综合征 (艾滋病) 患者的自杀风险明显更高. 然而,从1987年到1989年,这种风险下降了,这可能是由于治疗和护理的改善.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 精神病学是一种精神病学.
背景情况:
- 获得性免疫缺陷综合征 (艾滋病) 对影响心理健康提出了独特的挑战.
- 患有慢性和限制生命的疾病的人群中自杀风险需要仔细考虑.
研究的目的:
- 确定美国艾滋病患者 (PWA) 自杀的发生率,危险因素,趋势和方法.
- 为此群体预防自杀的临床实践和公共卫生策略提供信息.
主要方法:
- 使用国家卫生统计中心的死亡率数据 (1987-1989).
- 与公众可访问的艾滋病监测数据进行交叉引用,以计算观察人年.
- 在PWA中确定了自杀,使用死亡证明表明艾滋病和自杀.
主要成果:
- 在1987年至1989年期间,PWA记录了165起自杀事件.
- PWA的自杀率比一般男性人口高7.4倍.
- 药物自我中毒是最常见的方法;自杀风险从1987年到1989年显著下降.
结论:
- 艾滋病患者面临着更高的自杀风险,需要在他们的护理中进行例行风险评估.
- 在处方可能致命的药物时,仔细考虑自杀风险至关重要.
- 观察到的自杀率下降令人鼓舞,可能反映出艾滋病毒/艾滋病治疗和护理方面的进步.
相关概念视频
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

